Monthly Prescribing Reference

ACEi/ARB Withdrawal Linked to Worse Outcomes in Hospitalized HF Patients

The analysis looks at the mortality rate for those who continued or started ACEi/ARB treatment and those who discontinued or did not initiate the treatment. Withdrawal of angiotensin-converting enzyme ...
Healio

Clinical decision support tool improves ACEi/ARB reinitiation rates for veterans with CKD

Please provide your email address to receive an email when new articles are posted on . HOUSTON — A personalized alert tool may improve use of angiotensin-converting enzyme inhibitors and angiotensin ...
Monthly Prescribing Reference

ACEi/ARB Use Lowers Incidence of Appropriate ICD Shock

(HealthDay News) — For patients with cardiomyopathy, use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is associated with significantly lower incidence of ...
TCTMD

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...
Heart

Model-based cost-effectiveness analysis of first-line pharmacotherapy combinations in adults with chronic heart failure and reduced ejection fraction

Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
MedPage Today

ACEIs and ARBs in Chronic Kidney Disease: A Delicate Balance

The side effects of ACEIs and ARBs may be resulting in less frequent use in a population that could benefit from these medications. A new study found that continuous ACEI/ARB use prior to dialysis ...
News Medical

Is ACEI, ARB use linked to testing positive for COVID-19?

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current ...
Medscape

Fewer Deaths in Hospitalized COVID Patients on an ACEi or ARB

Patients who had been taking an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) for preexisting hypertension had lower in-hospital mortality but stayed longer in ...
Medscape

ACEI/ARBs Linked With Survival in Hypertensive, Chinese COVID-19 Patients

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalized COVID-19 patients with hypertension and on treatment with an renin-angiotensin system ...
Renal & Urology News

Statin, ACEI/ARB Nonadherence Dangerous After Heart Attack

(HealthDay News) — Nonadherence to angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) and/or statins following acute myocardial infarction (AMI) is associated with ...
MedPage Today

In Patients with CKD, Compliance is a Barrier to ACEI/ARB Therapy

—Getting kidney patients to stick with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) presents a real challenge. Here are some tips that may help. When it ...